BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24359993)

  • 1. Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening.
    Asch WS; Bia MJ
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):106-13. PubMed ID: 24359993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-renal transplant malignancies: Opportunities for prevention and early screening.
    Turshudzhyan A
    Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Pre)malignancies of the female anogenital tract in renal transplant recipients.
    Meeuwis KA; van Rossum MM; Hoitsma AJ; de Hullu JA
    Transplantation; 2011 Jan; 91(1):8-10. PubMed ID: 21452406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.
    Lim WH; Turner RM; Chapman JR; Ma MK; Webster AC; Craig JC; Wong G
    Transplantation; 2014 Apr; 97(8):817-25. PubMed ID: 24521777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-novo malignancies after kidney transplantation: A long-term observational study.
    Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
    PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.
    Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D
    Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
    Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Malignant Neoplasms in Renal Transplant Patients.
    Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genitourinary tumor following kidney transplantation: a multicenter study.
    Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
    Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cancer in renal transplant recipients.
    Sheil AG; May J; Mahoney JF; Horvath JS; Johnson JR; Tiller DJ; Stewart JH
    Proc Eur Dial Transplant Assoc; 1980; 17():502-6. PubMed ID: 7017697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical course of de-novo malignancies in renal allograft recipients.
    Winkelhorst JT; Brokelman WJ; Tiggeler RG; Wobbes T
    Eur J Surg Oncol; 2001 Jun; 27(4):409-13. PubMed ID: 11417989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of de novo malignancy in the liver transplant recipient.
    Chandok N; Watt KD
    Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.